DE4115215A1 - Indolderivate - Google Patents

Indolderivate

Info

Publication number
DE4115215A1
DE4115215A1 DE4115215A DE4115215A DE4115215A1 DE 4115215 A1 DE4115215 A1 DE 4115215A1 DE 4115215 A DE4115215 A DE 4115215A DE 4115215 A DE4115215 A DE 4115215A DE 4115215 A1 DE4115215 A1 DE 4115215A1
Authority
DE
Germany
Prior art keywords
carboxylic acid
formula
amide
quinuclidin
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE4115215A
Other languages
German (de)
English (en)
Inventor
Henning Dr Boettcher
Christoph Dr Seyfried
Gerd Batoszyk
Klaus-Otto Dr Minck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE4115215A priority Critical patent/DE4115215A1/de
Priority to EP19920107132 priority patent/EP0512350A3/de
Priority to CS921305A priority patent/CS130592A3/cs
Priority to AU16044/92A priority patent/AU1604492A/en
Priority to TW081103571A priority patent/TW221807B/zh
Priority to PL29445792A priority patent/PL294457A2/xx
Priority to NO92921831A priority patent/NO921831L/no
Priority to MX9202152A priority patent/MX9202152A/es
Priority to HU9201550A priority patent/HU208136B/hu
Priority to KR1019920007824A priority patent/KR920021507A/ko
Priority to CA002068238A priority patent/CA2068238A1/en
Priority to ZA923351A priority patent/ZA923351B/xx
Priority to JP4143642A priority patent/JPH05155886A/ja
Priority to IE148892A priority patent/IE921488A1/en
Publication of DE4115215A1 publication Critical patent/DE4115215A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE4115215A 1991-05-10 1991-05-10 Indolderivate Withdrawn DE4115215A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE4115215A DE4115215A1 (de) 1991-05-10 1991-05-10 Indolderivate
EP19920107132 EP0512350A3 (en) 1991-05-10 1992-04-27 Indole derivatives
CS921305A CS130592A3 (en) 1991-05-10 1992-04-29 3-/indole-2-carboxamido/quinuclidine, process for preparing thereof and apharmaceutical composition which contains it
AU16044/92A AU1604492A (en) 1991-05-10 1992-05-05 Indole derivatives
TW081103571A TW221807B (enExample) 1991-05-10 1992-05-07
PL29445792A PL294457A2 (en) 1991-05-10 1992-05-07 Method of obtaining novel 3-(indolocarbonamide-2)-quinuclidines
NO92921831A NO921831L (no) 1991-05-10 1992-05-08 Indolderivater, fremgangsmaate for fremstilling derav samtpreparater inneholdende et slikt derivat
MX9202152A MX9202152A (es) 1991-05-10 1992-05-08 Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
HU9201550A HU208136B (en) 1991-05-10 1992-05-08 Process for producing new indole derivatives and pharmaceutical compositions comprising same
KR1019920007824A KR920021507A (ko) 1991-05-10 1992-05-08 인돌 유도체
CA002068238A CA2068238A1 (en) 1991-05-10 1992-05-08 Indole derivatives
ZA923351A ZA923351B (en) 1991-05-10 1992-05-08 Indole derivatives
JP4143642A JPH05155886A (ja) 1991-05-10 1992-05-11 インドール誘導体
IE148892A IE921488A1 (en) 1991-05-10 1992-07-01 Indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4115215A DE4115215A1 (de) 1991-05-10 1991-05-10 Indolderivate

Publications (1)

Publication Number Publication Date
DE4115215A1 true DE4115215A1 (de) 1992-11-12

Family

ID=6431344

Family Applications (1)

Application Number Title Priority Date Filing Date
DE4115215A Withdrawn DE4115215A1 (de) 1991-05-10 1991-05-10 Indolderivate

Country Status (14)

Country Link
EP (1) EP0512350A3 (enExample)
JP (1) JPH05155886A (enExample)
KR (1) KR920021507A (enExample)
AU (1) AU1604492A (enExample)
CA (1) CA2068238A1 (enExample)
CS (1) CS130592A3 (enExample)
DE (1) DE4115215A1 (enExample)
HU (1) HU208136B (enExample)
IE (1) IE921488A1 (enExample)
MX (1) MX9202152A (enExample)
NO (1) NO921831L (enExample)
PL (1) PL294457A2 (enExample)
TW (1) TW221807B (enExample)
ZA (1) ZA923351B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8405891A (en) * 1990-08-31 1992-03-30 Nippon Shinyaku Co. Ltd. Indole derivative and medicine
IT1255467B (it) * 1992-07-29 1995-11-02 Dompe Farmaceutici Spa Ammidi acriliche farmacologicamente attive
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
EP1381603A2 (en) 2000-08-18 2004-01-21 PHARMACIA & UPJOHN COMPANY Quinuclidine-substituedaryl moieties for treatment of disease ( nicotinic acetylcholine receptor ligands )
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282875A1 (en) 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
DE10045112A1 (de) * 2000-09-11 2002-03-21 Merck Patent Gmbh Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
KR100614900B1 (ko) 2001-10-02 2006-08-25 파마시아 앤드 업존 캄파니 엘엘씨 질병의 치료를 위한 아자비시클릭-치환된 융합-헤테로아릴화합물
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
DE10164139A1 (de) * 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
MXPA04008152A (es) 2002-02-19 2005-09-08 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
JP2005523288A (ja) 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
JP2005537297A (ja) 2002-08-01 2005-12-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アルファ−７ｎａｃｈｒ活性を有する１ｈ−ピラゾールおよび１ｈ−ピロール−アザビシクロ化合物
WO2009158375A1 (en) * 2008-06-25 2009-12-30 Abbott Laboratories Aza-cylic indole- 2 -carboxamides and methods of use thereof
US8642638B2 (en) 2008-11-19 2014-02-04 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
PH12012502252A1 (en) 2010-05-17 2022-10-05 Envivo Pharmaceuticals Inc A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
RU2635522C2 (ru) 2012-05-08 2017-11-13 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
EP0289170B1 (en) * 1987-04-25 1993-06-23 Beecham Group Plc Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben

Also Published As

Publication number Publication date
IE921488A1 (en) 1992-11-18
NO921831L (no) 1992-11-11
CS130592A3 (en) 1992-11-18
PL294457A2 (en) 1992-11-16
HU208136B (en) 1993-08-30
EP0512350A2 (de) 1992-11-11
KR920021507A (ko) 1992-12-18
HUT61541A (en) 1993-01-28
NO921831D0 (no) 1992-05-08
ZA923351B (en) 1993-01-27
CA2068238A1 (en) 1992-11-11
JPH05155886A (ja) 1993-06-22
AU1604492A (en) 1992-11-12
MX9202152A (es) 1992-11-01
HU9201550D0 (en) 1992-07-28
TW221807B (enExample) 1994-03-21
EP0512350A3 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
DE4115215A1 (de) Indolderivate
DE60027648T2 (de) Sulfonamide enthaltende indolderivate
EP0648767B1 (de) Piperidine und Piperazine, die Wirkungen auf das z.n.s. Zeigen
DE69524528T2 (de) ZNS wirksames (R)-(-)-2-[5-(4-Fluorophenyl)-3-pyridylmethylaminomethyl]chroman
EP0683166B1 (de) 3-Indolylpiperidine
DE60309057T2 (de) Azabicycloderivate als antagonisten des muscarinischen rezeptors
JPH05221968A (ja) ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換誘導体
JPH05221969A (ja) ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換アミン誘導体
DE3717561A1 (de) Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE2419970A1 (de) Tertiaere cyclische amine und verfahren zu ihrer herstellung
EP0722942A1 (de) Indolpiperidin-Derivate
DE4127849A1 (de) Benzodioxanderivate
EP0736525A1 (de) Benzonitrile und -fluoride als 5-HT Agonisten und Antagonisten
DE4407047A1 (de) Acetamide
DD244133A5 (de) Verfahren zur herstellung von substituierten 2-oxindolen als analgetische und entzuendungshemmende mittel
EP0407844B1 (de) Indolderivate
EP0007399B1 (de) Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
EP0206225A2 (de) Indolderivate
DE10259244A1 (de) N-(Indolethyl-)cycloamin-Verbindungen
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
EP0450345B1 (de) Indolderivate
DE3421641A1 (de) Indolderivate
DE4226527A1 (de) 1,4-Benzodioxanderivate
DE69310567T2 (de) In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität
DE69104416T2 (de) Acylbenzoxazolinone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee